Moderna tests mRNA tech against seasonal flu
NCT ID NCT05606965
Summary
This study tested a new flu vaccine made with mRNA technology, similar to Moderna's COVID-19 vaccine. It involved 172 healthy adults and compared the new vaccine's safety and ability to trigger an immune response against standard flu shots. The main goal was to see if the mRNA vaccine was safe and how well it protected against flu strains one month after vaccination.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University in St. Louis
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.